Although Marchand et al. [54] suggest that GSK3 and mTOR inhibition impinge independently upon TFEB, inhibition of GSK3-mediated mTORC1 activity has recently been shown by others to reduce cell proliferation, increase lysosomal acidification and enhance autophagy in MCF-7 human breast cancer cells [19]. Here, MTOR is linked to breast carcinoma.